Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

European Research Council grant · Running

ORACLE Optimize risk prediction after myocardial infarction through artificial intelligence and multidimensional evaluation

Coordinator
Fundacion Para La Investigacion De Malaga En Biomedicina Y Salud, Spain
Runs
1 April 2024 to 31 March 2029
Status
Running
EU funding
€1.4m
Total cost
€1.4m
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101117469

What the project is doing

In the project's own words, from its summary on CORDIS.

Myocardial infarction (MI) is a leading cause of death worldwide. After MI, long-term antithrombotic therapy is crucial to prevent recurrent events, but increases bleeding, that also impacts morbidity and mortality. Giving these competing risks prediction tools to forecast ischemic and bleeding are of paramount importance to inform clinical decisions, but their current precision is limited. Improve events prediction, by discovering novel and innovative markers of risk would have a tremendous impact on therapeutic decisions and patients outcome.

I hypothesize that using innovative multidimensional information from wearable devices, biomarkers, behavioral patterns and non-invasive imaging, integrated through artificial intelligence computation, we may discover novel computational biomarkers of risk and improve current standards of risk prediction. In this project, I will enroll a large cohort of MI patients, whereby prospective collection of consolidated and innovative potential risk predictors will take place, in order to generate a comprehensive and multidimensional dataset.

I will collect data from state-of-the-art non-invasive imaging, blood biomarkers, wearable medical devices of continuous heart electrical activity, sweat, mobility and behavioral patterns to create a large physiological time series allowing patients deep phenotyping. We will therefore analyze data leveraging artificial intelligence computation to find relevant associations with clinical outcomes, and compare new algorithms with current risk prediction tools.

This research will increase our knowledge on bleeding and ischemic risk factors, enabling enhanced capability predictions models. In the near future, we hypothesize that our clinically-guided Artificial Intelligence algorithm might be integrated in clinical practice, helping clinicians to inform treatment decisions, patients to better understand their risk profile, finally setting a common ground for shared patient/physician decisions.

Topics

Who is involved

OrganisationCityCountryRole
Fundacion Para La Investigacion De Malaga En Biomedicina Y SaludMalagaSpainCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI